Table 4.
association between treatment profile and adherence to HAART among respondents
| Characteristic | Odds ratio | 95% confidence interval | p-value | |
|---|---|---|---|---|
| Lower | Upper | |||
| Median age | ||||
| < 43 | 1 | 0.779 | 1.443 | 0.724 |
| ≥ 43 | 1.056 | |||
| Type of residence | ||||
| Rural | 1 | 0.674 | 1.306 | 0.714 |
| Urban | 0.938 | |||
| Educational status | ||||
| Formal education | 1 | 0.801 | 2.150 | 0.280 |
| No formal education | 1.313 | |||
| Drink alcohol | ||||
| No | 1 | 0.262 | 0.559 | <0.001 |
| Yes | 0.382 | |||
| HAART combination | ||||
| Second line | 1 | 2.523 | 5.358 | <0.001 |
| First line | 3.677 | |||
| HAART dosing | ||||
| Once daily | 1 | 0.381 | 0.661 | <0.001 |
| Twice daily | 0.502 | |||
| Side effects | ||||
| No | 1 | 0.547 | 1.129 | 0.192 |
| Yes | 0.786 | |||
| Food and fluid restriction | ||||
| No | 1 | 0.000 | 0.999 | |
| Yes | 0.000 | |||
| CD4 count | ||||
| < 500 | 1 | 0.543 | 0.964 | 0.027 |
| ≥ 500 | 0.723 | |||
| Family support | ||||
| No | 1 | 0.544 | 0.995 | 0.046 |
| Yes | 0.736 | |||
| Co-morbidity | ||||
| No | 1 | 0.659 | 1.330 | 0.714 |
| Yes | 0.936 | |||
HAART: highly active antiretroviral therapy